After months of international availability, the Dexcom G7 constant glucose monitor received its FDA clearance to distribute in the US. Ahead of the wide rollout, we got to go hands-on with a demo ...

DEXCOM G4 PLATINUM continuous glucose monitor by Dexcom Dexcom announced that the FDA has approved its Dexcom G4 Platinum continuous glucose monitor (CGM) for patients with diabetes. Dexcom announced ...

San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

The FDA has cleared Dexcom’s Stelo Glucose Biosensor System for over-the-counter use by people aged 18 years and older. The system is the first continuous glucose monitor to be made available without ...

It takes two: After making its commercial debut early this year, Dexcom’s latest continuous glucose monitor is wrapping up 2023 by connecting with its first automated insulin pump partner, courtesy of ...

DexCom, Inc. DXCM recently announced the first-ever registry committed toward keeping a track on the outcomes of patients and healthcare professionals using Continuous Glucose Monitoring (CGM) in ...

DexCom, Inc. DXCM recently announced the first-ever registry committed toward keeping a track on the outcomes of patients and healthcare professionals using Continuous Glucose Monitoring (CGM) in ...

EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring, its global partners and Dexcom Warriors will once again help the world ...

Glucose-monitor maker DexCom Inc. (NASDAQ: DXCM) was among the top three gainers within the healthcare sector on July 28, advancing 2.33% in the season after gapping higher at the open. The company ...

The Life Sciences division of Google (or Alphabet, I should say) envisions a paradigm in which sugar-monitoring contact lenses and wellness wristbands are ubiquitous. News that it’s working on a ...

Thursday, after-hours Dexcom Inc (NASDAQ:DXCM) reported fourth-quarter 2023 earnings with sales of $1.03 billion, up 27% Y/Y (+26% on an organic basis), almost in line with the consensus estimate of ...